imiquimod has been researched along with Autoimmune Disease in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Assani, I; Chen, L; Huang, RZ; Jin, Q; Kang, YY; Li, Y; Liao, ZX; Lv, SM; Su, M; Sun, B; Wang, CG; Wang, DZ; Wang, JW; Wang, MX; Wu, XZ; Zhao, SF | 1 |
| Fan, T; He, X; Huang, X; Liu, R; Ruan, Q; Su, W; Wang, T; Wu, C | 1 |
| Ding, Y; Li, Y; Lu, J; Shi, Y; Xu, X; Yu, N | 1 |
| Alaverdyan, K; Chai, S; Fuchs, E; Gomez, NC; Kulukian, A; Larsen, SB; Naik, S; Polak, L; Sendoel, A; Yuan, S | 1 |
| Burnett, TJ; English, JC; Ferris, LK | 1 |
| Alexopoulou, L; Demaria, O; Desnues, B | 1 |
| Hengge, UR; Meykadeh, N | 1 |
7 other study(ies) available for imiquimod and Autoimmune Disease
| Article | Year |
|---|---|
Discovery of 2H-chromone-4-one based sulfonamide derivatives as potent retinoic acid receptor-related orphan receptor γt inverse agonists.
Topics: Amino Acid Sequence; Animals; Autoimmune Diseases; Chromones; Disease Models, Animal; Drug Development; Drug Inverse Agonism; Female; Humans; Imiquimod; Inflammation; Interleukin-17; Molecular Docking Simulation; Protein Binding; Protein Conformation; Pyrans; Receptors, Retinoic Acid; Skin; Structure-Activity Relationship; Sulfonamides; Th17 Cells | 2022 |
Treating Autoimmune Diseases by Targeting IL-23 with Gene-Silencing Pyrrole-Imidazole Polyamide.
Topics: Animals; Autoimmune Diseases; Female; Gene Silencing; Imidazoles; Imiquimod; Interleukin-23 Subunit p19; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Molecular Structure; Nylons; Psoriasis; Pyrroles; Uveitis | 2020 |
Local reinfusion of B10 cells is effective in the treatment of pustular psoriasis.
Topics: Autoimmune Diseases; Cell Differentiation; Humans; Imiquimod; Psoriasis; Skin | 2020 |
Inflammatory memory sensitizes skin epithelial stem cells to tissue damage.
Topics: Aminoquinolines; Animals; Autoimmune Diseases; Caspase 1; Cell Lineage; Chromatin; DNA-Binding Proteins; Epigenesis, Genetic; Epithelial Cells; Female; Imiquimod; Inflammasomes; Inflammation; Interleukin-1beta; Macrophages; Mice; Neoplasms; Regeneration; Skin; Stem Cells; Stress, Physiological; T-Lymphocytes; Wound Healing | 2017 |
Development of subacute cutaneous lupus erythematosus associated with the use of imiquimod to treat actinic keratoses.
Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aminoquinolines; Autoimmune Diseases; Female; Humans; Imiquimod; Keratosis, Actinic; Lupus Erythematosus, Cutaneous; Middle Aged; Retinitis; Severity of Illness Index | 2010 |
[Toll-like receptor 8: the awkward TLR].
Topics: Adaptive Immunity; Aminoquinolines; Animals; Autoimmune Diseases; Clinical Trials, Phase I as Topic; Cytokines; Drug Evaluation, Preclinical; Gene Expression Regulation; Imiquimod; Immunity, Innate; Ligands; Lupus Erythematosus, Systemic; Membrane Glycoproteins; Mice; Models, Immunological; Neoplasms; RNA, Viral; Signal Transduction; Species Specificity; Toll-Like Receptor 3; Toll-Like Receptor 7; Toll-Like Receptor 8; Virus Diseases | 2012 |
[Topical immunomodulators in dermatology].
Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Asthma; Autoimmune Diseases; Bowen's Disease; Child; Cyclopropanes; Dermatitis, Atopic; Dinitrochlorobenzene; Female; Follow-Up Studies; Herpes Simplex; Humans; Imidazoles; Imiquimod; Immunity, Cellular; Immunocompromised Host; Immunoglobulin A; Immunosuppressive Agents; Lichen Sclerosus et Atrophicus; Male; Molluscum Contagiosum; Papillomavirus Infections; Precancerous Conditions; Skin Diseases; Skin Diseases, Viral; Skin Neoplasms; Tacrolimus; Time Factors; Warts | 2003 |